theophylline has been researched along with Carcinoma, Ovarian Epithelial in 1 studies
Carcinoma, Ovarian Epithelial: A malignant neoplasm that originates in cells on the surface EPITHELIUM of the ovary and is the most common form of ovarian cancer. There are five histologic subtypes: papillary serous, endometrioid, mucinous, clear cell, and transitional cell. Mutations in BRCA1, OPCML, PRKN, PIK3CA, AKT1, CTNNB1, RRAS2, and CDH1 genes are associated with this cancer.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Liu, L | 1 |
Cai, S | 1 |
Han, C | 1 |
Banerjee, A | 1 |
Wu, D | 1 |
Cui, T | 1 |
Xie, G | 1 |
Zhang, J | 1 |
Zhang, X | 1 |
McLaughlin, E | 1 |
Yin, M | 1 |
Backes, FJ | 1 |
Chakravarti, A | 1 |
Zheng, Y | 1 |
Wang, QE | 1 |
1 other study available for theophylline and Carcinoma, Ovarian Epithelial
Article | Year |
---|---|
ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2
Topics: Aldehyde Dehydrogenase 1 Family; Animals; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Prot | 2020 |